Yeah "21", I too am confused on the great news of 48% ORR and the stock is down. Could be sell on the news or it's heavy manipulation from those that don't want shares going north from here and MAYBE they are waiting for the oral presentation that takes place in a little bit - Who knows, only the nose knows - GLTU
Yes, it's frustrating but af's comments won't matter, what really matter is what big pharms think about oncs data. Is that good enough to pull the trigger???? I certainly think so but my thoughts won't matter as well.